NCT04335669 - NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC | Biotech Hunter

Enrollment

325

Participants

Timeline

Start Date

December 20, 2019

Primary Completion Date

September 30, 2035

Study Completion Date

September 30, 2035

Conditions

Breast CancerTriple Negative Breast Neoplasms

Interventions

DRUG

epirubicin, cyclophosphamide, paclitaxel, carboplatin, pembrolizumab

Cytotoxic agents.

DRUG

epirubicin, cyclophosphamide, capecitabine, paclitaxel, carboplatin, pembrolizumab

Cytotoxic agents.

Trial Locations (24)

2100

Rigshospitalet, Copenhagen

3400

Nordsjællands Hospital, Hillerød

4700

Regionsjælland Næstved Sygehus, Næstved

6300

Sønderborg sygehus, Sønderborg

6700

Sydvestjysk Sygehus, Esbjerg

7100

Vejle Hospital, Vejle

Vejle syghus, Vejle

9000

Aalborg Universitetshospita, Aalborg

20501

Skåne University Hospital, Department of Oncology, Malmo

291 85

Centralsjukhuset i Kristianstad, Kristianstad

501 82

Södra Älvsborgs Hospital, Borås

803 24

Gävle hospital, Department of Oncology, Gävle

413 46

Sahlgrenska University Hospital, Department of Oncology, Gothenburg

302 33

Halmstad Hospital, Department of Surgery, Halmstad

551 85

Ryhov Hospital, Jönköping

652 30

Karlstad Hospital, Karlstad

701 85

Örebro University Hospital, Department of Oncology, Örebro

112 19

Capio S:t Göran Hospital, Department of Oncology, Stockholm

118 61

Södersjukhuset, Department of Oncology, Stockholm

851 86

Sundsvall hospital, Sundsvall

907 37

Norrland University Hospital, Department of Oncology, Umeå

753 09

Academical Hospital, Department of Oncology, Uppsala

352 34

Växjö Hospital, Department of Oncology, Vaxjo

721 89

Västmanlands Hopsital Västerås, Västerås

All Listed Sponsors

collaborator

Swedish Breast Cancer Group

OTHER

collaborator

Danish Breast Cancer Cooperative Group

OTHER

lead

Lund University Hospital

OTHER